EFFICACY OF AZTREONAM IN PULMONARY EXACERBATIONS OF CYSTIC-FIBROSIS

被引：24

作者：

BOSSO, JA

BLACK, PG

MATSEN, JM

机构：

[1] UNIV UTAH,SCH MED,DEPT PEDIAT,SALT LAKE CITY,UT 84112

[2] UNIV UTAH,SCH MED,DEPT PATHOL,SALT LAKE CITY,UT 84112

来源：

PEDIATRIC INFECTIOUS DISEASE JOURNAL | 1987年 / 6卷 / 04期

关键词：

D O I：

10.1097/00006454-198704000-00010

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：393 / 397

页数：5

共 22 条

[1]

ALDER KB, 1983, JAMA, V249, P1615

[2]

ARONOFF SC, 1984, ANTIMICROB AGENTS CH, V25, P279, DOI 10.1128/AAC.25.2.279

[3]

BAUER AW, 1966, AM J CLIN PATHOL, V45, P493

[4] IS ANTI-PSEUDOMONAS THERAPY WARRANTED IN ACUTE RESPIRATORY EXACERBATIONS IN CHILDREN WITH CYSTIC-FIBROSIS [J].

BEAUDRY, PH ;

MARKS, MI ;

MCDOUGALL, D ;

DESMOND, K ;

RANGEL, R .

JOURNAL OF PEDIATRICS, 1980, 97 (01) :144-147

[5] PENETRATION OF AZTREONAM INTO HUMAN BRONCHIAL-SECRETIONS [J].

BECHARD, DL ;

HAWKINS, SS ;

DHRUV, R ;

FRIEDHOFF, LT .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (02) :263-264

[6] SHOULD PULMONARY EXACERBATIONS IN CYSTIC-FIBROSIS BE TREATED WITH ANTIBIOTICS [J].

BOSSO, JA .

DRUG INTELLIGENCE & CLINICAL PHARMACY, 1984, 18 (10) :825-826

[7]

GUAY DRP, 1985, CLIN PHARMACY, V4, P516

[8] NAD-DEPENDENT INHIBITION OF PROTEIN-SYNTHESIS BY PSEUDOMONAS-AERUGINOSA TOXIN [J].

IGLEWSKI, BH ;

KABAT, D .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (06) :2284-2288

[9] INVITRO ACTIVITY OF AZTHREONAM, A MONOBACTAM ANTIBIOTIC [J].

JACOBUS, NV ;

FERREIRA, MC ;

BARZA, M .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (05) :832-838

[10]

Lennette E.H., 1980, MANUAL CLIN MICROBIO, P195

← 1 2 3 →